Exane Derivatives Has Raised Boston Scientific (BSX) Position; Energizer Holdings, Inc. (ENR) Had 7 Bullish Analysts

April 20, 2018 - By Marie Mckinney

Boston Scientific Corporation (NYSE:BSX) Logo

Among 10 analysts covering Edgewell Personal Care Company (ENR) (NYSE:ENR), 7 have Buy rating, 0 Sell and 3 Hold. Therefore 70% are positive. Edgewell Personal Care Company (ENR) had 49 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was upgraded by Deutsche Bank to “Buy” on Thursday, January 4. The firm has “Hold” rating given on Thursday, August 4 by Jefferies. The stock of Energizer Holdings, Inc. (NYSE:ENR) has “Buy” rating given on Monday, April 4 by Goldman Sachs. As per Friday, January 8, the company rating was downgraded by Jefferies. The firm has “Buy” rating by Citigroup given on Thursday, August 4. The stock of Energizer Holdings, Inc. (NYSE:ENR) has “Outperform” rating given on Friday, May 5 by RBC Capital Markets. KeyBanc Capital Markets upgraded Energizer Holdings, Inc. (NYSE:ENR) on Wednesday, July 19 to “Overweight” rating. UBS maintained Energizer Holdings, Inc. (NYSE:ENR) rating on Thursday, August 4. UBS has “Neutral” rating and $50 target. RBC Capital Markets maintained the shares of ENR in report on Tuesday, October 24 with “Buy” rating. The stock of Energizer Holdings, Inc. (NYSE:ENR) earned “Equal-Weight” rating by Morgan Stanley on Thursday, February 1. See Energizer Holdings, Inc. (NYSE:ENR) latest ratings:

12/04/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $64 New Target: $67 Maintain
01/02/2018 Broker: RBC Capital Markets Rating: Buy New Target: $65.0 Maintain
01/02/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $60 New Target: $63 Maintain
25/01/2018 Broker: Jefferies Rating: Hold New Target: $61.0 Maintain
16/01/2018 Broker: KeyBanc Capital Markets Rating: Buy New Target: $64.0 Maintain
16/01/2018 Broker: SunTrust Rating: Buy New Target: $70.0 Maintain
04/01/2018 Broker: Jefferies Rating: Hold New Target: $52.0 Maintain
04/01/2018 Broker: Deutsche Bank Old Rating: Hold New Rating: Buy Old Target: $49 Upgrade
22/11/2017 Broker: KeyBanc Capital Markets Rating: Buy New Target: $55.0 Maintain
10/11/2017 Broker: Citigroup Rating: Buy Old Target: $54 New Target: $52 Maintain

Exane Derivatives increased Boston Scientific (BSX) stake by 11826.09% reported in 2017Q4 SEC filing. Exane Derivatives acquired 2,720 shares as Boston Scientific (BSX)’s stock rose 7.69%. The Exane Derivatives holds 2,743 shares with $68.09 million value, up from 23 last quarter. Boston Scientific now has $39.85 billion valuation. The stock decreased 0.17% or $0.05 during the last trading session, reaching $28.89. About 5.76 million shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 9.97% since April 20, 2017 and is uptrending. It has underperformed by 1.58% the S&P500.

Investors sentiment increased to 1.34 in 2017 Q4. Its up 0.30, from 1.04 in 2017Q3. It is positive, as 36 investors sold BSX shares while 158 reduced holdings. 86 funds opened positions while 174 raised stakes. 1.18 billion shares or 2.38% less from 1.21 billion shares in 2017Q3 were reported. Amalgamated Bancorporation accumulated 180,895 shares or 0.12% of the stock. Nuveen Asset Management Ltd Liability invested 0.02% in Boston Scientific Corporation (NYSE:BSX). Keybank Association Oh reported 14,931 shares stake. Fdx Advisors Incorporated holds 19,650 shares. Hanson Mcclain has invested 0% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Pacad Inv Limited accumulated 77,600 shares. 95,370 are held by First Republic Inv Mngmt. Loring Wolcott And Coolidge Fiduciary Advisors Limited Liability Partnership Ma holds 0% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 10,103 shares. Moreover, Barclays Public Ltd Company has 0.05% invested in Boston Scientific Corporation (NYSE:BSX) for 2.30M shares. North Star Invest Mgmt Corporation, a Illinois-based fund reported 1,080 shares. Alliancebernstein Lp owns 2.23 million shares or 0.04% of their US portfolio. Dorsey & Whitney Trust Limited Liability Corporation has invested 0.04% in Boston Scientific Corporation (NYSE:BSX). Art Advsr Lc has 0.04% invested in Boston Scientific Corporation (NYSE:BSX) for 32,800 shares. Taurus Asset Management Lc has 2.16% invested in Boston Scientific Corporation (NYSE:BSX) for 592,785 shares. California State Teachers Retirement Systems has 2.27M shares for 0.12% of their portfolio.

Since October 30, 2017, it had 0 insider buys, and 15 sales for $7.82 million activity. Shares for $243,074 were sold by Pierce David A on Thursday, January 11. The insider Sorenson John Bradley sold 14,150 shares worth $381,949. On Wednesday, March 14 the insider Ballinger Kevin J. sold $1.21M. Another trade for 15,835 shares valued at $399,865 was made by Phalen Michael P. on Friday, December 29. 60,209 shares were sold by Brennan Daniel J., worth $1.68 million on Monday, March 19. Shares for $2.26 million were sold by Fitzgerald Joseph Michael.

Among 32 analysts covering Boston Scientific Corporation (NYSE:BSX), 26 have Buy rating, 0 Sell and 6 Hold. Therefore 81% are positive. Boston Scientific Corporation had 92 analyst reports since July 27, 2015 according to SRatingsIntel. RBC Capital Markets upgraded the stock to “Top Pick” rating in Friday, January 5 report. Argus Research upgraded Boston Scientific Corporation (NYSE:BSX) on Thursday, September 1 to “Buy” rating. The stock of Boston Scientific Corporation (NYSE:BSX) has “Buy” rating given on Wednesday, November 29 by Cowen & Co. The stock of Boston Scientific Corporation (NYSE:BSX) has “Outperform” rating given on Friday, October 27 by BMO Capital Markets. The firm earned “Outperform” rating on Friday, June 9 by RBC Capital Markets. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Buy” rating by Nomura on Thursday, March 17. The stock has “Buy” rating by Stifel Nicolaus on Thursday, October 26. The rating was upgraded by Goldman Sachs on Thursday, August 27 to “Neutral”. The stock has “Neutral” rating by Wedbush on Friday, July 29. The firm has “Buy” rating given on Monday, October 2 by RBC Capital Markets.

Exane Derivatives decreased Bco Santander Adr (NYSE:SAN) stake by 39,277 shares to 295,009 valued at $1.93B in 2017Q4. It also reduced Oxford Lane Cap (NASDAQ:OXLC) stake by 2,715 shares and now owns 7,028 shares. National Oilwell (NYSE:NOV) was reduced too.

The stock decreased 0.37% or $0.22 during the last trading session, reaching $59.46. About 609,180 shares traded. Energizer Holdings, Inc. (NYSE:ENR) has declined 6.26% since April 20, 2017 and is downtrending. It has underperformed by 17.81% the S&P500.

Since February 13, 2018, it had 6 insider buys, and 0 sales for $513,477 activity. The insider BENDER ANTHONY J bought $72,526. The insider HILL JOHN N bought 5,000 shares worth $250,200. HOOVER R DAVID bought 1,000 shares worth $52,938. Shares for $30,084 were bought by HUNTER JOHN C III. On Wednesday, February 14 Johnson James C bought $52,947 worth of Energizer Holdings, Inc. (NYSE:ENR) or 1,000 shares.

Investors sentiment increased to Infinity in 2017 Q4. Its up Infinity, from 0 in 2017Q3. It improved, as 0 investors sold Energizer Holdings, Inc. shares while 0 reduced holdings. 0 funds opened positions while 1 raised stakes. 32,036 shares or 104.47% more from 15,668 shares in 2017Q3 were reported. The Pennsylvania-based Vantage Invest Advsr Limited Liability Corp has invested 0% in Energizer Holdings, Inc. (NYSE:ENR). Paradigm Advsr Ltd Liability Corp, Missouri-based fund reported 7,076 shares. Gemmer Asset Mgmt Lc invested in 0.01% or 466 shares. Leavell Inv invested 0.05% in Energizer Holdings, Inc. (NYSE:ENR).

Boston Scientific Corporation (NYSE:BSX) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>